Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ashitani, J.-i.
Right arrow Articles by Matsukura, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ashitani, J.-i.
Right arrow Articles by Matsukura, S.
(Chest. 1998;113:788-794.)
© 1998 American College of Chest Physicians

Elevated Pleural Fluid Levels of Defensins in Patients With Empyema

Jun-ichi Ashitani MD1; Hiroshi Mukae MD1; Masamitsu Nakazato MD1; Haruko Taniguchi MD1; Kazuhiko Ogawa MD2; Shigeru Kohno MD, FCCP2; and Shigeru Matsukura MD1

1 From the Third Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan
2 From the Miyazaki Medical College, Miyazaki, Japan, and The Second Department of Internal Medicine, Nagasaki University School of Medicine, Nagasaki, Japan

Background: Defensins, also known as human neutrophil peptides, are antimicrobial peptides present in the azurophil granules of neutrophils. We measured their level in pleural effusion in various pulmonary diseases to investigate whether they could be used as a diagnostic marker in the differential diagnosis of specific pleural diseases.

Patients and participants: We analyzed pleural effusion samples collected from 61 patients, including 50 exudates (11 with empyema, 3 parapneumonic, 15 tuberculous, 18 neoplastic, 3 miscellaneous) and 11 transudates as controls.

Measurements: Defensins were measured by radioimmunoassay and also analyzed by reverse-phase high-performance liquid chromatography. The concentrations of interleukin (IL)-8 and granulocyte colony-stimulating factor (G-CSF) in pleural effusion fluid were measured by enzyme-linked immunosorbent assay to examine the correlation between these cytokines and defensins.

Results: The concentration of defensins in all samples of empyema was >5,100 ng/mL and the mean concentration (13,265.8±1,895.2 ng/mL) in these samples was the highest among other groups. The concentration in the other 50 pleural effusion samples tested was <2,800 ng/mL. Defensins were mostly of the mature type in empyema. Pleural effusion levels of IL-8 and G-CSF in patients with empyema were also significantly higher than those in other samples. There was a significant correlation between defensins and IL-8 or G-CSF in pleural effusion fluid (r=0.762, and 0.827, respectively).

Conclusions: Our results suggest that the high effusion concentrations of defensins in pleural effusion may constitute an important component of the host defense system or may have a cytotoxic role in empyema. Our results also indicate that the high levels of IL-8 and G-CSF in empyema may indirectly explain the elevated levels of defensins by increasing the number of neutrophils in the pleural space.

Key Words: defensins • granulocyte colony-stimulating factor • interleukin 8 • pleural effusion • pleurisy

Submitted on May 9, 1997
Accepted on September 4, 1997




This article has been cited by other articles:


Home page
ThoraxHome page
H Mukae, H Iiboshi, M Nakazato, T Hiratsuka, M Tokojima, K Abe, J Ashitani, J Kadota, S Matsukura, and S Kohno
Raised plasma concentrations of {alpha}-defensins in patients with idiopathic pulmonary fibrosis
Thorax, July 1, 2002; 57(7): 623 - 628.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J.-i. Ashitani, H. Mukae, T. Hiratsuka, M. Nakazato, K. Kumamoto, and S. Matsukura
Elevated Levels of {alpha}-Defensins in Plasma and BAL Fluid of Patients With Active Pulmonary Tuberculosis
Chest, February 1, 2002; 121(2): 519 - 526.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
H. Mukae, H. Taniguchi, N. Matsumoto, H. Iiboshi, J.-i. Ashitani, S. Matsukura, and Y. Nawa
Clinicoradiologic Features of Pleuropulmonary Paragonimus westermani on Kyusyu Island, Japan
Chest, August 1, 2001; 120(2): 514 - 520.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Bdeir, W. Cane, G. Canziani, I. Chaiken, J. Weisel, M. L. Koschinsky, R. M. Lawn, P. G. Bannerman, B. S. Sachais, A. Kuo, et al.
Defensin Promotes the Binding of Lipoprotein(a) to Vascular Matrix
Blood, September 15, 1999; 94(6): 2007 - 2019.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. D. Befus, C. Mowat, M. Gilchrist, J. Hu, S. Solomon, and A. Bateman
Neutrophil Defensins Induce Histamine Secretion from Mast Cells: Mechanisms of Action
J. Immunol., July 15, 1999; 163(2): 947 - 953.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American College of Chest Physicians.